Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06068348
Study type Observational
Source University of Central Florida
Contact Amoy Fraser, PhD, CCRP, PMP
Phone 407-266-8742
Email amoy.fraser@ucf.edu
Status Recruiting
Phase
Start date October 7, 2021
Completion date October 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02072616 - Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma. Phase 3
Completed NCT02808884 - Cancer DNA Screening Pilot Study (CANDACE) N/A
Completed NCT02335151 - CTC Pancreatic Adenocarcinoma Phase 4
Completed NCT01015625 - Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer N/A
Recruiting NCT02602938 - Aspirin on CTCs of Advanced Breast and Colorectal Cancer Phase 2
Completed NCT02499458 - Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
Completed NCT03101046 - Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic Phase 2
Completed NCT02449837 - Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
Recruiting NCT02451384 - According CTC to Compare the Influences of Different Methods to Remove the PDAC N/A
Recruiting NCT01052818 - Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer N/A
Not yet recruiting NCT04239105 - Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
Recruiting NCT02554448 - Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy N/A
Recruiting NCT03156777 - Application Value of CTCs Detection for Advanced Gastric Cancer Patients N/A
Completed NCT02345473 - Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy N/A
Not yet recruiting NCT04229121 - Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
Completed NCT02955173 - Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer N/A
Completed NCT03340844 - Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors N/A
Active, not recruiting NCT03381326 - CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
Completed NCT05502458 - Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor Phase 2
Enrolling by invitation NCT04972461 - Therapeutic Response Evaluation by CTC Expansion System